Tag: event preview

American Venous Forum's 22nd Annual Meeting

February 10-13, in Amelia Island, FL Breakthrough research, up-to-date treatment protocols and an exchange of knowledge among the leaders in venous disease are the focus of the 22nd Annual Meeting of the American venous F...Continue Reading


American Venous Forum's 22nd Annual Meeting

February 10-13, in Amelia Island, FL Breakthrough research, up-to-date treatment protocols and an exchange of knowledge among the leaders in venous disease are the focus of the 22nd Annual Meeting of the American venous F...Continue Reading


American Venous Forum Will Celebrate Its Silver Anniversary at Annual Meeting

The American Venous Forum (AV F) will celebrate its 25th Silver Anniversary Meeting from February 27 to March 2 at the Wigwam in Phoenix, AZ . About 500 physicians, surgeons and allied health professionals who care for pa...Continue Reading


American Venous Forum Will Celebrate Its Silver Anniversary at Annual Meeting

The American Venous Forum (AV F) will celebrate its 25th Silver Anniversary Meeting from February 27 to March 2 at the Wigwam in Phoenix, AZ . About 500 physicians, surgeons and allied health professionals who care for pa...Continue Reading


Annual Scientific Meeting Preview SIR 2013: IR Reaches Out, Stresses Inclusiveness with Programming

by Gary P. Siskin, MD, FSIR More than 5,000 physicians, scientists and allied health professionals are expected to attend the Society of Interventional Radiology’s 38th Annual Scientific Meeting April 13–18 i...Continue Reading


Annual Scientific Meeting Preview SIR 2013: IR Reaches Out, Stresses Inclusiveness with Programming

by Gary P. Siskin, MD, FSIR More than 5,000 physicians, scientists and allied health professionals are expected to attend the Society of Interventional Radiology’s 38th Annual Scientific Meeting April 13–18 i...Continue Reading


Enrollment Complete for EKOS Corporation SEATTLE II Trial

EKOS Corporation, a privately held medical device company located in Bothell, WA, recently announced the completion of its second major trial for the treatment of pulmonary embolism (PE). In a 150 patient single arm pros...Continue Reading


Enrollment Complete for EKOS Corporation SEATTLE II Trial

EKOS Corporation, a privately held medical device company located in Bothell, WA, recently announced the completion of its second major trial for the treatment of pulmonary embolism (PE). In a 150 patient single arm pros...Continue Reading


Event Preview—The VEITHsymposium

by Curtis Walker As of November 18, 2008, the VEITHsymposium, an annual meeting dedicated to presenting information that is new and important in the treatment of vascular disease, will be halfway through its fourth decad...Continue Reading


Event Preview—The VEITHsymposium

by Curtis Walker As of November 18, 2008, the VEITHsymposium, an annual meeting dedicated to presenting information that is new and important in the treatment of vascular disease, will be halfway through its fourth decad...Continue Reading